...
首页> 外文期刊>British journal of clinical pharmacology >Patient participation in medication reviews is desirable but not evidence‐based: a systematic literature review
【24h】

Patient participation in medication reviews is desirable but not evidence‐based: a systematic literature review

机译:希望患者参加药物审查,但不能基于证据:系统的文献审查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim The aim of this systematic literature review is to investigate which types of patient participation in medication reviews have been practiced and what is known about the effects of patient participation within the medication review process. Methods A systematic literature review was performed in multiple databases using an extensive selection and quality assessment procedure. Results In total, 37 articles were included and most were assessed with a weak or moderate quality. In all studies patient participation in medication reviews was limited to the level of information giving by the patient to the professional, mainly on actual drug use. Nine studies showed limited results of effects of patient participation on the identification of drug related problems. Conclusions The effects of patient participation are not frequently studied and poorly described in current literature. Nevertheless, involving patients can improve patients' knowledge, satisfaction and the identification of drug related problems. Patient involvement is now limited to information sharing. The profit of higher levels of patient communication and shared decision making is until now, not supported by evidence of its effectiveness.
机译:目的本系统文献综述的目的是调查已实施了哪些类型的患者参与药物评价,以及有关患者参与药物评价过程的影响的已知信息。方法采用广泛的选择和质量评估程序,在多个数据库中进行系统的文献综述。结果总共纳入了37篇文章,大多数被评估为中度或弱度。在所有研究中,患者参与用药审查仅限于患者向专业人员提供的信息水平,主要是关于实际用药情况。九项研究表明,患者参与对药物相关问题的识别效果有限。结论在当前文献中,对患者参与的影响并不经常研究并且描述不充分。然而,让患者参与可以提高患者的知识,满意度和发现与药物有关的问题。现在,患者的参与仅限于信息共享。到目前为止,更高水平的患者沟通和共同决策的收益尚无证据表明其有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号